9.32
price down icon2.10%   -0.20
pre-market  Pre-mercato:  9.25   -0.07   -0.75%
loading

Compass Pathways Plc Adr Borsa (CMPS) Ultime notizie

pulisher
May 04, 2026

What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN

May 04, 2026
pulisher
May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026
pulisher
Apr 30, 2026

These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill

Apr 30, 2026
pulisher
Apr 29, 2026

BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Apr 29, 2026
pulisher
Apr 28, 2026

This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm

Apr 28, 2026
pulisher
Apr 28, 2026

Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart

Apr 28, 2026
pulisher
Apr 27, 2026

Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance

Apr 27, 2026
pulisher
Apr 27, 2026

These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com

Apr 27, 2026
pulisher
Apr 26, 2026

Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm

Apr 25, 2026
pulisher
Apr 24, 2026

Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa

Apr 24, 2026
pulisher
Apr 24, 2026

FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India

Apr 24, 2026
pulisher
Apr 24, 2026

FDA grants priority voucher to Compass for psilocybin treatment - Investing.com

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com

Apr 24, 2026
pulisher
Apr 24, 2026

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 24, 2026
pulisher
Apr 24, 2026

What's Going On With Enveric Biosciences Stock On Friday? - Sahm

Apr 24, 2026
pulisher
Apr 23, 2026

Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat

Apr 23, 2026
pulisher
Apr 23, 2026

How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN

Apr 23, 2026
pulisher
Apr 22, 2026

Compass Pathways (NASDAQ:CMPS) Shares Down 7.3%Should You Sell? - MarketBeat

Apr 22, 2026
pulisher
Apr 22, 2026

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Apr 22, 2026
pulisher
Apr 22, 2026

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136% - sharewise.com

Apr 22, 2026
pulisher
Apr 21, 2026

Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On? - Sahm

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways partners with Osmind on psychedelic treatment delivery By Investing.com - Investing.com South Africa

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways partners with Osmind on psychedelic treatment delivery - Investing.com

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways (NASDAQ:CMPS) Hits New 1-Year HighHere's What Happened - MarketBeat

Apr 21, 2026
pulisher
Apr 21, 2026

Company News for Apr 21, 2026 - Yahoo Finance UK

Apr 21, 2026
pulisher
Apr 20, 2026

This 4/20, Wall Street Is Betting on More Than Marijuana - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? - Barchart

Apr 20, 2026
pulisher
Apr 20, 2026

Compass Pathways (NASDAQ:CMPS) Shares Gap UpHere's Why - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 20, 2026
pulisher
Apr 20, 2026

Investors Purchase Large Volume of Call Options on Compass Pathways (NASDAQ:CMPS) - MarketBeat

Apr 20, 2026
pulisher
Apr 19, 2026

Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' - Sahm

Apr 19, 2026
pulisher
Apr 16, 2026

Compass Pathways : Notice of 2026 AGM - marketscreener.com

Apr 16, 2026
pulisher
Apr 15, 2026

Short Interest in Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Rises By 39.5% - MarketBeat

Apr 15, 2026
pulisher
Apr 15, 2026

Board-backed 2026 AGM agenda set at Compass Pathways (NASDAQ: CMPS) - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling NDA and 2026 Launch Readiness - Yahoo Finance

Apr 15, 2026
pulisher
Apr 14, 2026

Compass Pathways opens grant program for psilocybin training - Investing.com

Apr 14, 2026
pulisher
Apr 09, 2026

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 09, 2026
pulisher
Apr 07, 2026

COMPASS Pathways stock: Why psychedelic therapy potential draws investors now - AD HOC NEWS

Apr 07, 2026
BKD BKD
$14.03
price up icon 0.07%
$32.59
price up icon 0.22%
CHE CHE
$427.55
price up icon 0.38%
UHS UHS
$165.40
price down icon 0.40%
$175.95
price down icon 3.34%
DVA DVA
$157.04
price up icon 1.92%
Capitalizzazione:     |  Volume (24 ore):